Correction: Dual TLR9 and PD-L1 targeting unleashes dendritic cells to induce durable antitumor immunity 🔗 Access full article via Journal for ImmunoTherapy of CancerShare:TwitterFacebookEmailRedditMoreLinkedInWhatsAppTelegramMastodon
